A Study of Viracept in HIV-Positive Women
NCT00002171 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give Viracept plus stavudine (d4T) plus lamivudine (3TC) to HIV-positive women with a CD4 count \<= 400 cells/mm3. This study also examines how the body handles Viracept when given with d4T and 3TC.
Conditions
- HIV Infections
Interventions
- DRUG
-
Nelfinavir mesylate
Sponsors & Collaborators
-
Agouron Pharmaceuticals
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 13 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
NCT00004999 ·Status: SUSPENDED ·Phase: PHASE2
-
A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials
NCT02187107 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
NCT00084253 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
NCT00002347 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002411 ·Status: COMPLETED ·Phase: NA
-
A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002227 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 141W94 in Combination With Other Anti-HIV Drugs
NCT00002372 ·Status: COMPLETED ·Phase: PHASE1
-
Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine
NCT00000838 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
NCT00002177 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
NCT00002215 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment
NCT00002216 ·Status: COMPLETED ·Phase: NA
-
Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
NCT00158821 ·Status: COMPLETED ·Phase: PHASE3
-
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
NCT00046176 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.
NCT00081588 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).
NCT00359021 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
NCT00004985 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
NCT00002368 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002307 ·Status: COMPLETED ·Phase: NA
-
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
NCT00000859 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00002168 ·Status: COMPLETED ·Phase: NA
-
Dose Optimisation of Stavudine for the Treatment of HIV Infection
NCT02670772 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
NCT00002211 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
NCT00004852 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
NCT00592124 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
NCT00002202 ·Status: COMPLETED ·Phase: PHASE3